Healthcare -
Biotechnology - NASDAQ - US
$ 2.85
-0.697 %
$ 3.45 M
Market Cap
-0.66
P/E
LIPO - STOCK-BASED COMPENSATION
Stock-based Compensation LIPO - Lipella Pharmaceuticals Inc.
1.36 M
LAST VALUE
36.35%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR